NCT06703918 Study on Clostridium Difficile Infection in Infants
| NCT ID | NCT06703918 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First People's Hospital of Hangzhou |
| Condition | Clostridium Difficile Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-07-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.
Eligibility Criteria
Inclusion Criteria: * Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group). Exclusion Criteria: * Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06703918 clinical trial?
This trial is open to participants of all sexes, aged 0 Months or older, up to 24 Months, studying Clostridium Difficile Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06703918 currently recruiting?
Yes, NCT06703918 is actively recruiting participants. Contact the research team at wanglq921206@163.com for enrollment information.
Where is the NCT06703918 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06703918 clinical trial?
NCT06703918 is sponsored by First People's Hospital of Hangzhou. The trial plans to enroll 150 participants.